Michael J. Coghlan

A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side Effects

Michael J. Coghlan, Peer B. Jacobson, Ben Lane et al. · Molecular Endocrinology · 2003 · 221 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets

Kyle W. Sloop, Francis S. Willard, Martin Brenner et al. · Diabetes · 2010 · 140 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Nonsteroidal Selective Glucocorticoid Modulators:  the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines

Steven W. Elmore, Michael J. Coghlan, David D. Anderson et al. · Journal of Medicinal Chemistry · 2001 · 111 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation

Michael J. Coghlan, Murali Gopalakrishnan, Char‐Chang Shieh · European Journal of Pharmacology · 2003 · 109 citations

Life Sciences, Cell Biology, Oncology +14

Nonsteroidal Selective Glucocorticoid Modulators:  The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines

Philip R. Kym, Michael E. Kort, Michael J. Coghlan et al. · Journal of Medicinal Chemistry · 2003 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17